ARCHIVES

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Howard Hughes Medical Institute Seeks up to 25 New Researchers

January 17, 2014

In Brief: Reauthorization May Be Wrapped Up This Week As House, Senate Work Toward Compromise

October 14, 1988

ACS Clinical Awards Available For 1996

March 31, 1995

NIC Grants Appeals Process Explained

April 19, 1985

Why Four? NCI Official Challenged To Explain Rational For Proposed Number Of Groups

March 25, 2011

NCAB Approves 8 Cancer Centers As Comprehensive

October 4, 1991